UpHealth, Inc.

UpHealth reported Q2 2023 revenue of $37.8 million, down from $43.7 million in Q2 2022. Gross margin was 53%, up from 48% in the prior-year quarter, and adjusted EBITDA was $5.3 million versus $4.0 million a year ago. Segment revenue was $16.8 million for virtual care infrastructure, $15.5 million for services, and $5.5 million for integrated care management. For the full year 2023, management raised guidance to the top end of revenue of $127 million to $135 million, gross margin of 43% to 45%, and adjusted EBITDA exceeding $15 million.

Sam Meckey framed the quarter as evidence that UpHealth’s restructuring and narrower focus are working, saying the company is “not the same company it was a year ago.” He emphasized a pivot toward higher-growth, higher-margin businesses, including U.S. telehealth, services, and integrated care management, while also highlighting the new UpHealth Innovation Lab and AI/data-driven offerings. His tone was constructive and confident, with repeated comments about progress, stronger pipeline quality, and building toward growth in 2024.

Martin Beck focused on the financial impact of the portfolio changes and the underlying margin profile. He said Q2 gross margin was 53% versus 54% in Q1, adjusted EBITDA was $5.3 million versus $6.6 million in Q1, and unrestricted cash was over $46 million at June 30, 2023, helped by more than $54 million of net proceeds from the IGI sale and offset by a $10.3 million redemption of 2025 senior secured notes. He also noted $8.2 million of asset impairments and said legal expenses added back to adjusted EBITDA were just north of $3.6 million, mostly tied to Glocal arbitration and litigation, with legal costs expected to decline after Q3.

Analysts pressed management on why telehealth revenue had been roughly flat around $17 million despite growth in clients, and Sam said the business is seeing mix shifts between voice and video, customer onboarding timing, and language-mix effects, but no “alarming trends.” Questions also focused on the 6% pipeline increase and the 20% of opportunities “closed out”; management said that included both wins and losses, and that faster yes/no decisions are a positive sign. On sales spending, Sam said the company will add some commercial resources later in the year, likely offset by G&A reductions, and he reiterated that the company is actively testing AI/data products with strategic clients.